Page last updated: 2024-09-03

reboxetine and pnu-282987

reboxetine has been researched along with pnu-282987 in 1 studies

Compound Research Comparison

Studies
(reboxetine)
Trials
(reboxetine)
Recent Studies (post-2010)
(reboxetine)
Studies
(pnu-282987)
Trials
(pnu-282987)
Recent Studies (post-2010) (pnu-282987)
6261931841460123

Protein Interaction Comparison

ProteinTaxonomyreboxetine (IC50)pnu-282987 (IC50)
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)4.541
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)4.541

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreasen, JT; Christensen, JK; Mirza, NR; Nielsen, EØ; Olsen, GM; Peters, D; Redrobe, JP1

Other Studies

1 other study(ies) available for reboxetine and pnu-282987

ArticleYear
Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Journal of psychopharmacology (Oxford, England), 2011, Volume: 25, Issue:10

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Antidepressive Agents; Azepines; Benzamides; Bridged Bicyclo Compounds; Citalopram; Female; Male; Mice; Morpholines; Motor Activity; Nicotinic Agonists; Pyridines; Rats; Rats, Wistar; Reboxetine; Receptors, Nicotinic; Swimming; Xenopus laevis

2011